Saga Diagnostics to be acquired by Roche in transaction valued at up to USD 595 million
NOME portfolio company Saga Diagnostics has reached a major milestone, as Roche has entered into a definitive agreement to acquire the company in a transaction valued at up to $ 595 million, including commercial and regulatory milestone payments. The transaction is subject to customary closing ...